Evidence map›Paper›PMID 42683400›Full record

ArticleASM case reports2026

Emergence of

Amy L Leber, Sophonie J Oyeniran, Jonatan Lehtinen, Huanyu Wang

Abstract readCase Reports
In one paragraph

Article in ASM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amy L LeberDepartment of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0002-3075-3586
Sophonie J OyeniranDepartment of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0001-9372-3491
Jonatan LehtinenSolu Healthcare Oy, Helsinki, Finland.
Huanyu WangDepartment of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0002-5982-6371

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Case Summary: Two patients underwent preoperative nasal screening using Xpert SA Nasal Complete, and corresponding culture results were discordant with the molecular results. In both cases, the Xpert SA assay reported "SA detected and MRSA not detected," whereas culture and antimicrobial susceptibility testing (AST) demonstrated the presence of MRSA. Additional testing supported the culture-based identification of MRSA. Whole-genome sequencing and molecular typing revealed that both MRSA isolates harbored Conclusion: While NAATs remain highly sensitive and reliable tools for MRSA screening and the overall risk of FN MRSA detection may be low, our cases highlight the importance of ongoing surveillance of local MRSA epidemiology and understanding the genetic inclusivity of the molecular assays used for detection. In high-risk or targeted patients, consideration of reflex culture may be warranted.

Indexed as

molecular typingMRSA screeningStaphylococcus aureus

Identifiers

PMID42683400
PMCPMC13532282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.